12.02.2018
- Troubled Israeli generics giant Teva Pharmaceuticals is making "strong progress" on its turnaround plan, despite an even higher loss – approaching $12 billion – in the 2017 fourth...
31.08.2017
- Three weeks after announcing it would cut 350 jobs at two plants in Israel, generics producer Teva has trimmed the number back to 285. The company said it will only eliminate 65...
12.08.2014
- US generic drugmaker Mylan has shaved the top end of its full-year revenue and earnings forecasts slightly, citing delays in approval from the US Food and Drug Administration for...
16.05.2014
- Shortly before expiration of the patent on the multiple sclerosis treatment Copaxone, a US district court has dismissed a case by Teva Pharmaceutical Industries, subsidiary of the...
08.04.2014
- Teva Pharmaceutical Industries, U.S. subsidiary of the Israeli generics drugmaker, has asked the U.S. Supreme Court to stop a lower court ruling from going into effect while the...
24.06.2012
- Teva Pharmaceutical Industries rose more than 11% on Sunday after a U.S. court upheld Teva's patents for multiple sclerosis drug Copaxone well into 2015. Israel-based Teva, the...
11.05.2011
- Teva Pharmaceutical Industries, the world's largest generic drugmaker, met forecasts with a 14% rise in quarterly earnings on strong sales growth in Europe following last year's...
04.05.2011
- Teva Pharmaceutical Industries struck a deal to acquire U.S. specialty drugmaker Cephalon for nearly $7 billion, topping an unsolicited bid by Canada's Valeant Pharmaceuticals...
